|
|
.
See Category: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
See Header: Abnormal findings on diagnostic imaging of body structures
ICD-10 (CM) Code and Descriptor
|
R93.89 |
Abnormal findings on diagnostic imaging of other specified body structures
|
R9389 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 31.05%
|
26.92%
|
16.29%
|
9.10%
|
5.52%
|
3.43%
|
2.22%
|
1.48%
|
1.05%
|
0.74%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for R93.89*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
71250
|
CT THORAX DX C- |
15,852
|
15,855
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
12,236
|
12,256
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
9,275
|
791,379
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
9,146
|
9,171
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
6,799
|
8,443
|
|
G1004
|
CDSM NDSC |
6,480
|
7,057
|
|
71046
|
X-RAY EXAM CHEST 2 VIEWS |
6,448
|
6,454
|
|
71260
|
CT THORAX DX C+ |
5,985
|
5,985
|
|
76830
|
TRANSVAGINAL US NON-OB |
5,094
|
5,094
|
|
82565
|
ASSAY OF CREATININE |
4,626
|
4,628
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
4,571
|
4,574
|
|
76856
|
US EXAM PELVIC COMPLETE |
4,227
|
4,227
|
|
80053
|
COMPREHEN METABOLIC PANEL |
3,872
|
3,872
|
|
J3010
|
FENTANYL CITRATE INJECTION |
2,353
|
3,169
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
2,315
|
67,890
|
|
80048
|
METABOLIC PANEL TOTAL CA |
2,029
|
2,029
|
|
99213
|
OFFICE O/P EST LOW 20 MIN |
1,859
|
1,859
|
|
J2405
|
ONDANSETRON HCL INJECTION |
1,781
|
7,507
|
|
94729
|
CO/MEMBANE DIFFUSE CAPACITY |
1,754
|
1,754
|
|
74177
|
CT ABD & PELVIS W/CONTRAST |
1,647
|
1,647
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
R93.89 related to the following DRG Codes:
947-948
|
